Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("we" or "Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...
infectious form of the virus is identical to the ubiquitous form that rarely causes illness." Despite antibiotics and steroids Shepard continued to decline and only improved after the administration ...